Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Roudier

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Plos One|February 16, 2017
Long term treatment with abatacept or tocilizumab does not increase Epstein-Barr virus load in patients with rheumatoid arthritis - A three years retrospective studyNathalie Balandraud, Gaetan Texier, Emmanuel Massy, et al.
Joint Bone Spine|December 14, 2004
Clinical and pathophysiological significance of the autoimmune response to citrullinated proteins in rheumatoid arthritisMireille Sebbag, Sabine Chapuy-Regaud, Isabelle Auger, et al.
Frontiers in Immunology|July 12, 2021
In Rheumatoid Arthritis Patients, HLA-DRB1*04:01 and Rheumatoid Nodules Are Associated With ACPA to a Particular Fibrin EpitopeGuillaume Larid, Mikael Pancarte, Géraldine Offer, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2002
Paracrine in vivo inhibitory effects of hepatitis B virus X protein (HBx) on liver cell proliferation: an alternative mechanism of HBx-related pathogenesisJ Guilherme Tralhao, Jean Roudier, Serban Morosan, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 11, 2019
Peptidylarginine Deiminase Autoimmunity and the Development of Anti-Citrullinated Protein Antibody in Rheumatoid Arthritis: The Hapten-Carrier ModelIsabelle Auger, Nathalie Balandraud, Emmanuel Massy, et al.
Plos One|June 6, 2013
HLA-DRB1 genotypes and the risk of developing anti citrullinated protein antibody (ACPA) positive rheumatoid arthritisNathalie Balandraud, Christophe Picard, Denis Reviron, et al.
Chimerism|February 18, 2011
Cells from a vanished twin as a source of microchimerism 40 years laterLaurent Meric de Bellefon, Pierre Heiman, Sami B Kanaan, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 24, 2025
A tolerogenic plasmid inhibits autoantibody production triggered by immunization with human peptidyl arginine deiminase 4Philippe P Pagni, Vijetha Kumar, Nathalie C Lambert, et al.
Frontiers in Immunology|October 18, 2021
Corrigendum: Factors Predicting the Presence of Maternal Cells in Cord Blood and Associated Changes in Immune Cell CompositionMarina El Haddad, Karlin Karlmark, Xavier-Côme Donato, et al.
Arthritis and Rheumatism|December 1, 2007
Influence of -308 A/G polymorphism in the tumor necrosis factor alpha gene on etanercept treatment in rheumatoid arthritisSandrine Guis, Nathalie Balandraud, Julien Bouvenot, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Plos One|February 16, 2017
Long term treatment with abatacept or tocilizumab does not increase Epstein-Barr virus load in patients with rheumatoid arthritis - A three years retrospective studyNathalie Balandraud, Gaetan Texier, Emmanuel Massy, et al.
Joint Bone Spine|December 14, 2004
Clinical and pathophysiological significance of the autoimmune response to citrullinated proteins in rheumatoid arthritisMireille Sebbag, Sabine Chapuy-Regaud, Isabelle Auger, et al.
Frontiers in Immunology|July 12, 2021
In Rheumatoid Arthritis Patients, HLA-DRB1*04:01 and Rheumatoid Nodules Are Associated With ACPA to a Particular Fibrin EpitopeGuillaume Larid, Mikael Pancarte, Géraldine Offer, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 16, 2002
Paracrine in vivo inhibitory effects of hepatitis B virus X protein (HBx) on liver cell proliferation: an alternative mechanism of HBx-related pathogenesisJ Guilherme Tralhao, Jean Roudier, Serban Morosan, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 11, 2019
Peptidylarginine Deiminase Autoimmunity and the Development of Anti-Citrullinated Protein Antibody in Rheumatoid Arthritis: The Hapten-Carrier ModelIsabelle Auger, Nathalie Balandraud, Emmanuel Massy, et al.
Plos One|June 6, 2013
HLA-DRB1 genotypes and the risk of developing anti citrullinated protein antibody (ACPA) positive rheumatoid arthritisNathalie Balandraud, Christophe Picard, Denis Reviron, et al.
Chimerism|February 18, 2011
Cells from a vanished twin as a source of microchimerism 40 years laterLaurent Meric de Bellefon, Pierre Heiman, Sami B Kanaan, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 24, 2025
A tolerogenic plasmid inhibits autoantibody production triggered by immunization with human peptidyl arginine deiminase 4Philippe P Pagni, Vijetha Kumar, Nathalie C Lambert, et al.
Frontiers in Immunology|October 18, 2021
Corrigendum: Factors Predicting the Presence of Maternal Cells in Cord Blood and Associated Changes in Immune Cell CompositionMarina El Haddad, Karlin Karlmark, Xavier-Côme Donato, et al.
Arthritis and Rheumatism|December 1, 2007
Influence of -308 A/G polymorphism in the tumor necrosis factor alpha gene on etanercept treatment in rheumatoid arthritisSandrine Guis, Nathalie Balandraud, Julien Bouvenot, et al.
Pageof 6